re holding to the end23 Sep 2018 16:30
you are right there MISSK ….. RE; if PYC can move from 1p to 40p in one week on a 500k contract
why can't we.... and why are we at these levels still on our licence deal in JAN 2017 that is worth a hell of a lot more
as you well see from that RNS...…
announce the attainment of a US$2.0 million success milestone payment as part of the Chk1 licence agreement between its co-investment partner, the CRT Pioneer Fund, and Sierra Oncology, Inc. (NASDAQ: SRRA), formerly, until today, ProNAi Therapeutics, Inc.
Under the terms of the agreement, first announced on 27 September 2016, the fee has become payable as a result of the successful transfer of the two ongoing Phase 1 clinical trials to Sierra Oncology. Â Further payments in the aggregate amount of up to US$319.5 million may additionally become payable upon achievement of certain development, regulatory and commercial milestones. Sierra Oncology will also pay high single to low double digit royalties on the net sales of any product successfully developed.
IMHO SAR have not been rewarded on what's been achieve so far..... at all...
time will tell...
REGARDS....